Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 64

Infiltration of the phrenic nerve for chronic neck pain relief

Official title: Phrenic Afferences In Organic and Metabolic Illness: Central Sensitization

Run by University of Seville · NCT05605639 · Data updated 2026-11-12

This study is testing if injecting a pain-relieving medication into the phrenic nerve can help people with chronic neck pain feel better.

More Chronic Neck Pain trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 64 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Seville
Academic / other
Locations2 sites (Dos Hermanas, Seville and 1 other locations)
StatusRecruiting
StartedNovember 17, 2022
Main results expectedJuly 2025
Study endsJuly 2025
Registry record updatedDecember 11, 2024
Trial IDNCT05605639 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 64 who experience chronic neck pain and have peridiaphragmatic visceral disorders.

Probably not a fit

Patients with neurological, traumatic, oncological, infectious, or rheumatic conditions will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of phrenic nerve infiltration using bupivacaine on patients suffering from chronic neck pain associated with peridiaphragmatic visceral disorders. The study aims to determine whether this intervention can reduce pain sensitivity and improve neck symptoms through a randomized controlled trial. Participants will be assessed for changes in pain threshold, visual analogue scale scores, range of motion, and craniocervical questionnaires. The trial focuses on individuals without specific neurological, traumatic, or infectious causes for their pain.

Why it matters

Potential benefit: If successful, this approach could provide significant relief for patients suffering from chronic neck pain by addressing underlying visceral issues.

How similar studies have gone: While the specific approach of phrenic nerve infiltration is novel, previous studies have indicated that addressing visceral pain sources can improve chronic pain conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Over 18 and under 64 years old
* Patients attending to the physician or physical therapist with a main complaint of neck pain
* Presentation of any peridiaphragmatic visceral disorder.
* That the subject agrees to participate in the project by signing the informed consent.

Exclusion Criteria:

* Illness of neurological, traumatic, oncological, infectious or rheumatic (fibromyalgia, ankylosing spondylitis...) origin.
* Uncooperative subject.
* Severe psychiatric illness.
* Loss of Cognitive Ability.
* Contraindication to infiltration of the phrenic nerve.
* History of head, spinal or upper limb surgery
* History of infiltration for the neck pain in the previous 3 months
* History of physical therapy for the neck pain in the previous 30 days

Where it's running

  • Nacho Navarro Fisioterapia
    Dos Hermanas, Seville, Spain
    Recruiting
  • Crux Roxa
    Seville, Spain
    Recruiting

Study contacts

  • Principal investigator: Angel Oliva Pascual-Vaca, Dr — University of Seville
  • Study coordinator: Angel Oliva Pascual-Vaca, Dr
  • Email: angeloliva@us.es
  • Phone: 0034 954486524

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.